Sendero Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sendero Wealth Management's LLY Position: Q3 2026 in Review
Sendero Wealth Management reduced its Eli Lilly (LLY) stake by 2.8% in Q3 2026, selling an estimated $66.1K and leaving 1,958 shares worth $2.27M. The position accounts for 0.23% of the portfolio, ranked #76.
Sendero Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.42M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Sendero Wealth Management held 1,958 shares of Eli Lilly worth $2.27M as of Q3 2026.
- Sendero Wealth Management sold 56 Eli Lilly shares in Q3 2026, an estimated $66.1K.
- Eli Lilly made up 0.23% of Sendero Wealth Management's portfolio in Q3 2026, its #76 holding.
- Sendero Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Sendero Wealth Management's Eli Lilly position peaked at $2.42M in Q2 2026.
- 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Sendero Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.